Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53
about
Essential role of p53 in silica-induced apoptosisp53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum ConceptPhosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.Mutant TP53 posttranslational modifications: challenges and opportunities.Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifsMolecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53.Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-rasiNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53UBE4B targets phosphorylated p53 at serines 15 and 392 for degradationExtensive post-translational modification of active and inactivated forms of endogenous p53.p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression.Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.Dual Role of p53 in Innate Antiviral Immunity.Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathwaysActivation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeatChemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells.A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2.ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified.The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight.Activation of Casein Kinase II by Gallic Acid Induces BIK-BAX/BAK-Mediated ER Ca++-ROS-Dependent Apoptosis of Human Oral Cancer Cells.Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.Mutation of phosphoserine 389 affects p53 function in vivo.The ISWI ATPase Smarca5 (Snf2h) Is Required for Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells.Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis.
P2860
Q23917077-B3AC796A-7C13-4E7C-BC6E-32172090CE9BQ28079390-66FF4780-6223-4ACB-B002-9D386B33B169Q33783321-A48C4F83-F5D8-4327-850A-C9452C284EDBQ33818479-D534CDF4-642F-4FF8-BA3B-F761DC5C1A93Q34057911-BD8E8283-2864-42D4-AEFE-9E875B2755CEQ34158315-66EE38E5-279F-4FE3-82B1-46F8CAE0061AQ34332568-5C7E008E-B3DD-42FC-BFCD-1F4A3FD566CEQ35944785-75CE2AE0-82A2-479B-886B-F2C3FD1E6040Q36252884-4056613D-4ECF-4A0B-9527-8E0B3475F74FQ36771960-5C77DC75-42CE-48CD-8F6E-AD1B1FBA53EEQ37428803-84458B35-DBB4-4E87-93BF-BE990945139AQ37619644-27B6D065-AEBE-4864-9C31-30BADEE573DAQ37706903-DF4103BB-701F-41E9-9DE4-7B0AE5185A14Q38613932-2774D59C-04E9-40D8-8542-4CA745DF6343Q39454861-8D563CC1-CE83-4C65-8BE7-097331E32393Q39659924-09C03966-B96D-4D4B-9B8F-198D92453B7EQ40016514-1D72C015-40A5-4356-8E5C-C67391CB2406Q40844117-5075886D-BB8C-48C9-811C-7CBA82F29D31Q40847256-7CC092B1-F7F2-4047-8E14-92B284344ABCQ40958881-2D75E09D-D7AF-467F-AD46-A7D30CD261ADQ41187291-AD9A08D7-EE08-4E8C-A589-CA9F98E02A44Q41263744-0304E893-126A-4AE9-B98D-69E7686A08FAQ42370072-40256A7A-5C11-4EE2-BD7E-969368499928Q42775929-985A0BA7-1775-4503-AA2A-8BA61480AEDDQ42807102-A196D7C0-7942-4F9F-A8AE-847BB96264B9Q48146234-02AA1543-DE35-4B18-92E2-FB952D6A406FQ52579534-92FBB1E0-02EE-4538-B61A-15770E7D2B56
P2860
Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@ast
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@en
type
label
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@ast
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@en
prefLabel
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@ast
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@en
P2093
P2860
P356
P1476
Phosphorylation at Ser-15 and ...... ered compared to wild-type p53
@en
P2093
Anderson CW
Fiscella M
Lees-Miller SP
Sakaguchi K
Ullrich SJ
P2860
P304
P356
10.1073/PNAS.90.13.5954
P407
P577
1993-07-01T00:00:00Z